Evaluation of an Innovative Speech-enabled Translator in Emergency Settings

Completed

• Conditions: Diagnoses Disease

• Registration Number: NCT04788966
• Lead Sponsor: University Hospital, Geneva

Brief Summary

Survey-based satisfaction, performance and technical features evaluation of a speech-enabled fixed-phrase translation tool (BabelDR) in an emergency department.

Detailed Description

Not available

Study Timeline

• Study Start: 2018-11-29
• Primary Completion: 2020-01-20
• Study Completion: 2020-01-20
• Study First Submitted: 2021-02-19
• Status Verified: 2021-03
• Study First Submitted QC: 2021-03-04
• Last Update Submitted: 2021-03-04
• Study First Posted: 2021-03-09
• Last Update Posted: 2021-03-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 42

Inclusion Criteria

• As per inclusion criteria, patients were required to have no understanding of French, thus making a diagnostic interview by the doctors impossible.

Exclusion Criteria

• Exclusion criteria concerned patients who shared a common language with the doctor and/or were not able to read in their native language.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Satisfaction evaluation through a 4-point scale survey	During the consultation	Are patients' and doctors' satisfied with the use of BabelDr?
Technical features evaluation through a 4-point scale survey	During the consultation	Are the technical features appreciated by the doctors'?
Efficacy evaluation through a 2-point scale survey	During the consultation	Can BabelDr be efficient tool in an emergency context: are doctors' able to reach a diagnostic with the tool?

Trial Locations

Locations (1)

University Hospitals of Geneva (HUG); 🇨🇭 Geneva, Switzerland